Transgenic mouse models of Alzheimer's disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 17 (10) , S7-S12
- https://doi.org/10.1016/s0168-9525(01)02449-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68Nature, 2000
- Regulation of APP cleavage by α‐, β‐ and γ‐secretasesFEBS Letters, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic MiceHuman Molecular Genetics, 1997
- Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic MouseJournal of Neuroscience, 1997
- APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1Journal of Neuropathology and Experimental Neurology, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995